(Reuters) - Indivior's experimental drug to help fight America's growing opioid addiction crisis has been recommended for approval by a U.S. advisory panel, boosting its sales prospects as competitors threaten revenues from an older product.
from Reuters: Health News http://ift.tt/2ikDhhr
No comments:
Post a Comment